Laurent Marguerie

POS1288 FACTORS FOR EARLY INTRODUCTION OF BDMARDS IN PATIENTS WITH RIC AND CANCER IN REMISSION FOR LESS THAN 5 YEARS

H. Glerant, L. Villemain, Jean-Guillaume Letarouilly, Laurent Marguerie et autres

Background: For 20 years, bDMARDs have revolutionized the management of patients with inflammatory rheumatism, but their use is limited when patients have a history of cancer in remission for less than 5 years. Current data on their use in this specific context …

fr (code pays fourni par la source)

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

Guillaume Larid, Guy Baudens, Georges Tiemdjo-Djimaffo, Pascal Coquerelle et autres

The objectives of our study were to assess retention rate, safety, and predictive factors for retention of subcutaneous (SC) TNF inhibitors (TNFi) (adalimumab (ADA), etanercept (ETN), golimumab (GOL), and certolizumab pegol (CZP)) in axial spondyloarthritis (axSpA) depending on the line of treatment …

fr (code pays fourni par la source)

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study

Guillaume Larid, Guy Baudens, Alexis Dandurand, Pascal Coquerelle et autres

Objectives Previous studies demonstrated equivalence in terms of efficacy and safety of biosimilars (bsDMARDs) compared to original treatments (boDMARDs) and in switching situations. Less is known about what happens when initiating a bsDMARD in a molecule naïve patient. The objectives of our …

fr (code pays fourni par la source)

Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma

Joanna Kedra, Raphaèle Séror, Philippe Dieudé, Arnaud Constantin et autres

fr (code pays fourni par la source)

Biosimilaires versus princeps des anti-TNF sous cutanés : progression de la prescription et facteurs prédictifs de maintien à partir de la cohorte du réseau RIC France

A. Dandurand, Guy Baudens, Guillaume Larid, Éric Houvenagel et autres

fr (code pays fourni par la source)

Lymphoma complicating rheumatoid arthritis: results from a French case–control study

Joanna Kedra, Raphaèle Séror, Philippe Dieudé, Arnaud Constantin et autres

OBJECTIVES: To study the characteristics of B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin lymphoma complicating rheumatoid arthritis (RA) and to identify RA-related factors associated with their occurrence. METHODS: A multicentre case-control study was performed in France. Cases were patients with RA fulfilling ACR-EULAR …

fr (code pays fourni par la source)

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison

Jean-Guillaume Letarouilly, B. Flachaire, Céline Labadie, Maéva Kyheng et autres

OBJECTIVES: To evaluate the characteristics of patients (pts) with PsA treated by ustekinumab (UST) or secukinumab (SEK) and to compare real-world persistence of UST and SEK in PsA. METHODS: In this retrospective, national, multicentre cohort study, pts with PsA (CASPAR criteria or …

fr (code pays fourni par la source)

OP0125 LYMPHOMAS COMPLICATING RHEUMATOID ARTHRITIS: RESULTS OF A FRENCH MULTI-CENTRE CASE-CONTROL STUDY

Joanna Kedra, Raphaèle Séror, Philippe Dieudé, Anne-Marie Constantin et autres

fr (code pays fourni par la source)

FRI0348 PERSISTENCE OF SECUKINUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 409 PATIENTS

Jean-Guillaume Letarouilly, B. Flachaire, Céline Labadie, N. Cohen et autres

fr (code pays fourni par la source)

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network

Jean‐Hugues Salmon, Jean-Guillaume Letarouilly, Vincent Goëb, Lukshe Kanagaratnam et autres

OBJECTIVES: Data on abatacept (ABA) persistence in routine practice are limited. We aimed to study ABA persistence rates at 12 months, according to the date of initiation, and to analyze the factors associated with persistence at 12 months. METHODS: We performed an …

fr (code pays fourni par la source)

Lymphomas Complicating Rheumatoid Arthritis: Results of a French Multi-Centre Case-Control Study

Joanna Kedra, Raphaèle Séror, Philippe Dieudé, Arnaud Constantin et autres

fr, in, Maroc (code pays fourni par la source)

AB0760 DRUG SURVIVAL AND EFFICACY OF USTEKINUMAB AND SECUKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 186 PATIENTS

Jean-Guillaume Letarouilly, Jérémie Sellam, Pascal Richette, Philippe Dieudé et autres

fr (code pays fourni par la source)